Candriam Equities L Biotech.R USD Acc/ LU0942225912 /
| NAV2024-04-23 | Chg.+3.2500 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 253.5100USD | +1.30% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013 | - | - | - | - | - | - | - | - | - | - | - | 1.68 | - |
| 2014 | 8.32 | 7.40 | -9.88 | -5.03 | 2.83 | 10.18 | -3.18 | 11.14 | -1.05 | 9.67 | 3.04 | 0.65 | +36.60% |
| 2015 | 4.53 | 4.60 | 1.93 | -5.05 | 10.81 | 0.70 | 4.23 | -10.89 | -11.33 | 7.88 | 3.49 | 0.39 | +9.00% |
| 2016 | -23.19 | -4.52 | 3.75 | 3.75 | 5.66 | -8.35 | 12.63 | -2.32 | 4.04 | -12.67 | 9.19 | -2.77 | -18.88% |
| 2017 | 5.58 | 6.90 | 0.16 | 1.14 | -2.88 | 9.44 | 2.46 | 6.89 | 0.96 | -6.54 | 0.19 | 1.52 | +27.71% |
| 2018 | 6.76 | -4.56 | -2.08 | -3.16 | 4.67 | 0.87 | 4.47 | 4.19 | -2.05 | -13.96 | 4.19 | -8.27 | -10.56% |
| 2019 | 13.20 | 3.62 | -0.50 | -4.89 | -4.42 | 9.49 | -2.14 | -2.31 | -4.46 | 11.26 | 12.03 | 2.85 | +36.03% |
| 2020 | -5.22 | -1.47 | -4.93 | 12.42 | 9.55 | 1.34 | -2.95 | 0.90 | 0.77 | -2.60 | 9.52 | 3.04 | +20.18% |
| 2021 | 1.87 | -2.55 | -4.22 | 2.77 | -2.21 | 6.41 | -1.41 | 3.95 | -4.19 | 0.21 | -4.33 | 2.46 | -1.91% |
| 2022 | -10.53 | -1.50 | 6.10 | -7.18 | -3.92 | 3.56 | 4.77 | 1.59 | -1.85 | 6.56 | 6.24 | -2.81 | -0.72% |
| 2023 | 2.98 | -5.61 | 0.31 | 2.33 | -0.88 | 1.49 | -0.51 | -0.16 | -4.43 | -6.06 | 6.23 | 13.70 | +8.10% |
| 2024 | 1.56 | 1.41 | 0.03 | -6.01 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 15.87% | 18.61% | 16.14% | 20.15% | 22.74% |
| Sharpe ratio | -0.87 | 1.55 | -0.04 | -0.11 | 0.20 |
| Best month | +13.70% | +13.70% | +13.70% | +13.70% | +13.70% |
| Worst month | -6.01% | -6.06% | -6.06% | -10.53% | -10.53% |
| Maximum loss | -10.94% | -10.94% | -15.51% | -28.43% | -29.90% |
| Outperformance | -3.63% | - | -4.64% | +3.57% | +0.83% |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,949.4200 | +2.57% | +2.83% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 211.4500 | +5.40% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 1,955.1100 | +0.30% | -4.34% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,125.4199 | +5.66% | +15.45% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,289.8799 | +2.72% | +12.88% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 346.1400 | +3.43% | +16.75% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 311.7600 | +6.38% | +18.14% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 191.4000 | -1.38% | -5.43% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,748.7000 | +3.44% | +5.67% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 142.0600 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 569.2300 | +1.91% | +1.05% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,333.5898 | +2.45% | +2.45% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 187.6200 | +0.13% | -4.49% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 195.5200 | +0.99% | -2.13% | |
| Candriam Equities L Biotech.R US... | reinvestment | 253.5100 | +3.18% | +4.88% | |
| Candriam Equities L Biotech.C US... | reinvestment | 798.8100 | +2.29% | +2.34% | |
| Candriam Equities L Biotech.C US... | paying dividend | 733.7900 | +2.25% | +2.24% |
Performance
| YTD | -3.17% | ||
|---|---|---|---|
| 6 Months | +15.14% | ||
| 1 Year | +3.18% | ||
| 3 Years | +4.88% | ||
| 5 Years | +49.27% | ||
| Since start | +153.51% | ||
| Year | |||
| 2023 | +8.10% | ||
| 2022 | -0.72% | ||
| 2021 | -1.91% | ||
| 2020 | +20.18% | ||
| 2019 | +36.03% | ||
| 2018 | -10.56% | ||
| 2017 | +27.71% | ||
| 2016 | -18.88% | ||
| 2015 | +9.00% | ||
